Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Trovagene Inc (NASDAQ:TROV)

During the Trading Day
3.87 +0.22 / +6.03%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
3.87 0.00 / 0.00%
 
Volume: 732.00

Today’s Trading

Previous close3.65
Today’s open3.70
Day’s range3.57 - 4.02
Volume540,343
Average volume (3 months)599,769
Market cap$108.5M
Dividend yield--
Data as of 4:00pm ET, 02/09/2016

Growth & Valuation

Earnings growth (last year)-25.71%
Earnings growth (this year)-37.94%
Earnings growth (next 5 years)--
Revenue growth (last year)+8.07%
P/E ratioNM
Price/Sales292.69
Price/Book8.27

Competitors

 Today’s
change
Today’s
% change
CALACalithera Bioscience...-0.09-1.95%
VCYTVeracyte Inc-0.02-0.36%
LNTHLantheus Holdings In...+0.06+3.28%
TRILTrillium Therapeutic...+0.18+2.47%
Data as of 4:00pm ET, 02/09/2016

Financials

Next reporting dateMarch 10, 2016
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$280.2K
Annual profit (last year)-$14.3M
Net profit margin-5,112.99%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Antonius P. Schuh
Chief Financial Officer
Stephen L. Zaniboni
Corporate headquarters
San Diego, California

Forecasts

Partner Offers